Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition. [electronic resource]
- Oncoimmunology
- e1315495 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.